ExodusPoint Capital Management LP Buys 456,114 Shares of The Clorox Company (NYSE:CLX)

ExodusPoint Capital Management LP lifted its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 187.9% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 698,900 shares of the company's stock after acquiring an additional 456,114 shares during the quarter. Clorox comprises approximately 0.8% of ExodusPoint Capital Management LP's holdings, making the stock its 9th largest position. ExodusPoint Capital Management LP owned about 0.56% of Clorox worth $113,508,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the stock. California Public Employees Retirement System increased its holdings in shares of Clorox by 1.3% during the 4th quarter. California Public Employees Retirement System now owns 565,810 shares of the company's stock worth $91,893,000 after purchasing an additional 6,987 shares during the period. Public Employees Retirement System of Ohio grew its stake in shares of Clorox by 26.3% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 59,766 shares of the company's stock valued at $9,736,000 after purchasing an additional 12,428 shares during the period. Fifth Third Wealth Advisors LLC bought a new stake in shares of Clorox in the 4th quarter valued at approximately $204,000. Apollon Wealth Management LLC raised its holdings in shares of Clorox by 119.6% in the 4th quarter. Apollon Wealth Management LLC now owns 3,364 shares of the company's stock worth $546,000 after buying an additional 1,832 shares in the last quarter. Finally, Miracle Mile Advisors LLC bought a new position in shares of Clorox during the 4th quarter worth approximately $1,566,000. Institutional investors and hedge funds own 78.53% of the company's stock.

Clorox Stock Up 1.0 %

NYSE CLX traded up $1.41 during trading hours on Tuesday, reaching $140.31. 314,090 shares of the company's stock were exchanged, compared to its average volume of 1,283,895. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The Clorox Company has a one year low of $127.60 and a one year high of $171.37. The company's 50-day moving average is $149.58 and its two-hundred day moving average is $158.20. The company has a market capitalization of $17.28 billion, a price-to-earnings ratio of 38.29, a price-to-earnings-growth ratio of 2.62 and a beta of 0.61.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings data on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the previous year, the company posted $2.16 EPS. On average, analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be issued a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.48%. Clorox's dividend payout ratio (DPR) is presently 133.33%.

Analyst Ratings Changes

Several research analysts have issued reports on the company. Wells Fargo & Company dropped their price objective on Clorox from $161.00 to $155.00 and set an "equal weight" rating for the company in a research note on Wednesday, April 2nd. Royal Bank of Canada reissued a "sector perform" rating and set a $150.00 price target on shares of Clorox in a report on Thursday, January 30th. DA Davidson reduced their price target on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 5th. Evercore ISI raised their price objective on shares of Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Finally, JPMorgan Chase & Co. boosted their target price on Clorox from $171.00 to $173.00 and gave the stock a "neutral" rating in a report on Tuesday, February 4th. Three investment analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, Clorox has an average rating of "Hold" and an average price target of $159.00.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.